Axikin Pharmaceuticals

Axikin Pharmaceuticals, Inc. is a biopharmaceutical company based in San Diego, California, dedicated to the development and commercialization of small molecule therapeutics targeting respiratory, inflammatory, and autoimmune diseases. Founded in 2008, Axikin focuses on innovative treatments for conditions such as asthma, chronic obstructive pulmonary disease (COPD), inflammatory dermatoses, inflammatory bowel disease, and rheumatoid arthritis. The company's efforts include the development of novel therapeutics that aim to enhance treatment options for severe respiratory disorders and reduce inflammation. Axikin was established as a spin-off from Actimis Pharmaceuticals and continues to strive for advancements in healthcare solutions for complex diseases.